Schutz James J
Insider CIK 1367079 · OCLS Chief Operating Officer, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 3,571 | — | $0 | 184,516 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 30,000 | — | $0 | 67,733 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 4,285 | — | $0 | 167,733 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 5,357 | — | $0 | 172,018 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 1,428 | — | $0 | 177,375 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 3,928 | — | $0 | 178,803 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 1,785 | — | $0 | 182,731 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 67,733 | — | $0 | 0 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 5,271 | — | $0 | 188,087 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 20,000 | — | $0 | 147,733 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | H Expire deriv | 2019-01-14 | 2019-01-15 | 50,000 | — | $0 | 97,733 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | A Award deriv | 2018-07-20 | 2018-07-24 | 67,733 | — | $0 | 193,358 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2018-03-08 | 2018-03-08 | 2,473 | $3.99 | $9.9K | 35,858 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | A Award | 2018-01-02 | 2018-01-03 | 17,211 | — | $0 | 33,385 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-11-30 | 2017-12-04 | 345 | $4.95 | $1.7K | 16,174 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-11-29 | 2017-11-29 | 400 | $5.03 | $2.0K | 15,829 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-11-24 | 2017-11-27 | 254 | $5.05 | $1.3K | 15,429 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-08-10 | 2017-08-10 | 929 | $5.46 | $5.1K | 15,175 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | A Award | 2017-06-29 | 2017-06-30 | 2,406 | — | $0 | 14,246 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | A Award deriv | 2017-04-03 | 2017-04-05 | 30,000 | — | $0 | 133,658 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-03-03 | 2017-03-07 | 104 | $6.75 | $702 | 11,840 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2017-03-03 | 2017-03-07 | 696 | $6.78 | $4.7K | 11,736 | SEC↗ |
| SNOA Sonoma Pharmaceuticals, In | P Buy | 2016-12-08 | 2016-12-08 | 1,000 | $4.88 | $4.9K | 11,040 | SEC↗ |
| OCLS Oculus Innovative Sciences | A Award deriv | 2016-11-30 | 2016-12-02 | 50,000 | — | $0 | 103,658 | SEC↗ |
| OCLS Oculus Innovative Sciences | A Award | 2016-11-30 | 2016-12-02 | 3,535 | $4.81 | $17.0K | 10,040 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2016-08-15 | 2016-08-16 | 1,328 | $3.66 | $4.9K | 6,505 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2016-02-25 | 2016-02-29 | 5,000 | $1.00 | $5.0K | 25,885 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2014-11-17 | 2014-11-17 | 6,285 | $1.78 | $11.2K | 20,885 | SEC↗ |
| OCLS Oculus Innovative Sciences | A Award deriv | 2013-09-19 | 2013-09-20 | 100,000 | — | $0 | 232,298 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2013-08-16 | 2013-08-19 | 5,100 | $2.35 | $12.0K | 14,600 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2012-11-09 | 2012-11-09 | 11,400 | $0.80 | $9.1K | 65,000 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2012-11-09 | 2012-11-09 | 100 | $0.80 | $80 | 53,600 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2012-11-09 | 2012-11-09 | 1,000 | $0.78 | $780 | 66,500 | SEC↗ |
| OCLS Oculus Innovative Sciences | P Buy | 2012-11-09 | 2012-11-09 | 500 | $0.80 | $400 | 65,500 | SEC↗ |
| OCLS Oculus Innovative Sciences | A Award deriv | 2012-08-24 | 2012-08-27 | 150,000 | — | $0 | 1,147,000 | SEC↗ |
| OCLS Oculus Innovative Sciences | A Award deriv | 2012-03-07 | 2012-03-09 | 187,500 | — | $0 | 997,000 | SEC↗ |